Facts of Lyxumia (lixisenatide)?
What is LYXUMIA? Lyxumia is a diabetes medicine that contains the active substance lixisenatide. It is available as a solution for injection in a pre-filled pen that provides s either 10 micrograms or 20 micrograms of lixisenatide in each dose Available as (Form & Strength): Solution for injection in a pre-filled pen that provides s either 10 mg or 20 mg of lixisenatide in each do Lyxumia is a glucagon-like-peptide-1 (GLP-1) agonist that is taken once daily among people with type 2 diabetes. Lyxumia is the market name of lixisenatide and was approved for European use in February 2013. The primary benefit of Lyxumia has improved blood glucose levels, and it can be taken alongside another type 2 diabetes medication. Trade name: Lyxumia Generic name: Lixisenatide Drug class: GLP-1 receptor agonists (incretin mimetics) Manufacturer: Sanofi HOW DOES LYXUMIA (LIXISENATIDE) WO...